Last updated: 21 June 2019 at 1:51am EST

Associates Iv L P Venrock M... Net Worth




The estimated Net Worth of Associates Iv L P Venrock M... is at least $21.8 million dollars as of 27 April 2010. Associates M owns over 306,071 units of Alimera Sciences stock worth over $21,838,357 and over the last 15 years Associates sold ALIM stock worth over $0.

Associates M ALIM stock SEC Form 4 insiders trading

Associates has made over 1 trades of the Alimera Sciences stock since 2010, according to the Form 4 filled with the SEC. Most recently Associates bought 306,071 units of ALIM stock worth $3,366,781 on 27 April 2010.

The largest trade Associates's ever made was buying 306,071 units of Alimera Sciences stock on 27 April 2010 worth over $3,366,781. On average, Associates trades about 153,036 units every 0 days since 2010. As of 27 April 2010 Associates still owns at least 3,949,070 units of Alimera Sciences stock.

You can see the complete history of Associates M stock trades at the bottom of the page.



Insiders trading at Alimera Sciences

Over the last 15 years, insiders at Alimera Sciences have traded over $14,704,529 worth of Alimera Sciences stock and bought 8,598,915 units worth $59,337,384 . The most active insiders traders include Capital, Llc Armistice Capi..., Nicole Vitullo et Jesse I Treu. On average, Alimera Sciences executives and independent directors trade stock every 32 days with the average trade being worth of $468,137. The most recent stock trade was executed by Partners Lpjohnson David Ed... on 14 September 2023, trading 579,000 units of ALIM stock currently worth $1,962,810.



What does Alimera Sciences do?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.



What does Alimera Sciences's logo look like?

Alimera Sciences Inc. logo

Complete history of Associates M stock trades at Alimera Sciences

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
27 Apr 2010 Associates Iv L P Venrock M...
Acheter 306,071 $11.00 $3,366,781
27 Apr 2010
3,949,070


Alimera Sciences executives and stock owners

Alimera Sciences executives and other stock owners filed with the SEC include: